CD20 and CD38 expression on normal and CLL B-cells. Cells were... | Download Scientific Diagram
CD38-expressing macrophages drive age-related NAD+ decline | Nature Metabolism
CD38 - Wikipedia
Frontiers | CD38: A Significant Regulator of Macrophage Function
Cells | Free Full-Text | CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy
![PDF] CD38 and Regulation of the Immune Response Cells in Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c705fe469b5966b746cb77a8063ac6adff11c2ee/3-Figure1-1.png "PDF] CD38 and Regulation of the Immune Response Cells in Cancer | Semantic Scholar")
PDF] CD38 and Regulation of the Immune Response Cells in Cancer | Semantic Scholar
Frontiers | CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
CD38 affects the biological behavior and energy metabolism of nasopharyngeal carcinoma cells
Evolving roles of CD38 metabolism in solid tumour microenvironment | British Journal of Cancer
FITC Mouse Anti-Human CD38
CD38 in the age of COVID-19: a medical perspective | Physiological Reviews
-Flow-Cytometry-NB500-510-img0011.jpg "CD38 Antibody (HIT2) - BSA Free (NB500-510): Novus Biologicals")
CD38 Antibody (HIT2) - BSA Free (NB500-510): Novus Biologicals
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease:
Cureus | CD38: From Positive to Negative Expression after Daratumumab Treatment | Article
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma | Journal of Hematology & Oncology | Full Text
Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer
CD38 - Wikipedia
CD38: An important regulator of T cell function - ScienceDirect
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Frontiers | CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity
CD38, A Target for Immunotherapeutic Approaches in Cancer
Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review
Pathology Outlines - CD38
CD38, A Target for Immunotherapeutic Approaches in Cancer
